Episode 19: A Between the Biotech Waves Conversation with JeanFrancois Formela, Partner at Atlas Venture & multi-biotech company founder
Between the Biotech Waves
00:00
Xelixis - What Are the Early Investments?
The first oligo deal that I did was actually a company called Octomix. We ended up focusing on RTKs, and obviously, now, after many years, they actually have a couple of drugs that have been quite successful. In fact, we had a trademark, really, we don't know, on the word functional genomics; it's kind of funny in retrospect. And then, shortly thereafter, we started decode with Bob Nelson, our arch, and John de Leage, who is no longer results,. unfortunately, at growing out in de Leage. You recall there was a company in Tübingen, or I'm not sure if you're talking about Al
Transcript
Play full episode
